Antithrombotic therapy for durable left ventricular assist devices - current strategies and future directions.
Publication/Presentation Date
11-1-2022
Abstract
Left ventricular assist devices (LVADs) improve survival and quality of life for patients with advanced heart failure but are associated with high rates of thromboembolic and hemorrhagic complications. Antithrombotic therapy is required following LVAD implantation, though practices vary. Identifying a therapeutic strategy that minimizes the risks of thromboembolic and hemorrhagic complications is critical to optimizing patient outcomes and is an area of active investigation. This paper reviews strategies for initiating and maintaining antithrombotic therapy in durable LVAD recipients, focusing on those with centrifugal-flow devices.
Volume
38
Issue
6
First Page
628
Last Page
636
ISSN
0970-9134
Published In/Presented At
Weingarten, N., Song, C., Iyengar, A., Herbst, D. A., Helmers, M., Meldrum, D., Guevara-Plunkett, S., Dominic, J., & Atluri, P. (2022). Antithrombotic therapy for durable left ventricular assist devices - current strategies and future directions. Indian journal of thoracic and cardiovascular surgery, 38(6), 628–636. https://doi.org/10.1007/s12055-022-01409-z
Disciplines
Medicine and Health Sciences
PubMedID
36258825
Department(s)
Department of Surgery
Document Type
Article